Skip to main content
. 2019 Jul 9;28:100899. doi: 10.1016/j.rmcr.2019.100899

Fig. 2.

Fig. 2

The clinical courses of the three patients. The peripheral eosinophil level decreased rapidly in response to treatment with benralizumab. Lung function rapidly improved with benralizumab treatment following favorable results with mepolizumab. Abbreviations: Forced expiratory volume in 1 s (FEV1).